Bridger Makes Gains on New Orders
Bridger Aerospace Group Holdings, Inc. (NASDAQ: BAER) shares began Thursday positive. The Montana-based company. one of the nation’s largest aerial firefighting companies, today announced that is has received two separate 120-day task orders from the US Forest Service, each for two of its CL-415EAF “Super Scooper” aircraft. These procurements are noteworthy in that they were received early in the wildfire year and are for a record 120 days each.“These task orders recognize the Super Scoopers as one of the most effective tools in responding to wildfires as well as the Forest Service’s growing willingness to pre-position assets in order to more rapidly respond, helping to limit damage and better protect lives and property from this increasingly year-round threat,” commented CEO Sam Davis. “Securing these longer-term task orders also demonstrates the success of our strategy to have our fleet available and ready year-round to increase the visibility and predictability of our revenue.”Based in Belgrade, Montana, Bridger Aerospace Group Holdings, Inc. is one of the nation’s largest aerial firefighting companies. Bridger provides aerial firefighting and wildfire management services to federal and state government agencies, including the United States Forest Service, across the nation, as well as internationally.BAER shares edged up four cents, or 2.9%, to $1.93.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


